Use of Monocyte Chemoattractant Protein-1 in Monitoring of Renal Functions of Patients With Diabetic Nephropathy and Its Value as a Prognostic Marker in Assessing Renal Injury.

Turkish Journal of Biochemistry - Turkey
doi 10.5505/tjb.2014.58077
Full Text
Abstract

Available in full text

Date
Authors
Publisher

LookUs Bilisim A.S.

Related search

Monocyte Chemoattractant Protein-1 as a Diagnostic Marker for Detection of Hepatocellular Carcinoma in Egypt

Afro-Egyptian Journal of Infectious and Endemic Diseases
2016English

Significance of Renal Biopsy in Patients With Presumed Diabetic Nephropathy

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2012English

Deficiency for the Chemokine Monocyte Chemoattractant Protein-1 Aggravates Tubular Damage After Renal Ischemia/Reperfusion Injury

PLoS ONE
Multidisciplinary
2015English

Assessment of Urinary Kim-1 as Renal Injury Marker in Chronic Kidney Disease Patients.

2019English

A Dominant Negative Inhibitor Indicates That Monocyte Chemoattractant Protein 1 Functions as a Dimer.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1995English

Senescence-Associated Protein P400 Is a Prognostic Marker in Renal Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2013English

Enhanced Production of Monocyte Chemoattractant Protein-1 in Rheumatoid Arthritis.

Journal of Clinical Investigation
Medicine
1992English

Renal Dysfunction as a Marker of Increased Mortality in Patients With Pulmonary Thromboembolism

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2016English

Monocyte Chemoattractant Protein-1 in Human Atheromatous Plaques.

Journal of Clinical Investigation
Medicine
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy